These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10848375)

  • 1. Drug treatments for schizophrenia.
    Adams C; Wilson P; Gilbody S; Bagnall AM; Lewis R
    Qual Health Care; 2000 Mar; 9(1):73-9. PubMed ID: 10848375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].
    Laux G; Günther W
    Pharm Unserer Zeit; 2002; 31(6):572-6. PubMed ID: 12481515
    [No Abstract]   [Full Text] [Related]  

  • 3. Policy toward second-generation antipsychotic drugs: a cautionary note.
    Frank RG
    Psychiatr Serv; 2008 May; 59(5):521-2. PubMed ID: 18451008
    [No Abstract]   [Full Text] [Related]  

  • 4. Antipsychotic drugs: the costs and benefits.
    Harv Ment Health Lett; 2007 Mar; 23(9):5-6. PubMed ID: 17390404
    [No Abstract]   [Full Text] [Related]  

  • 5. [The contribution of clinical pharmacy: optimization of administration in schizophrenic disorders].
    Reinbold H
    Pharm Unserer Zeit; 2002; 31(6):566-71. PubMed ID: 12481514
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of schizophrenia pharmacotherapy.
    Soumerai SB; Law MR
    Am J Psychiatry; 2007 Apr; 164(4):678; author reply 678-9. PubMed ID: 17403984
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia.
    Revicki DA
    J Psychiatry Neurosci; 1997 Jul; 22(4):256-66. PubMed ID: 9262048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying time to relapse in schizophrenia. The role of long-acting injectable antipsychotics.
    Muller R
    Manag Care; 2014 Apr; 23(4 Suppl 1):2-3. PubMed ID: 25029779
    [No Abstract]   [Full Text] [Related]  

  • 9. The NIMH-CATIE Schizophrenia Study: what did we learn?
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2011 Aug; 168(8):770-5. PubMed ID: 21813492
    [No Abstract]   [Full Text] [Related]  

  • 10. Which atypical antipsychotic.
    Thomas CS; Lewis S
    Br J Psychiatry; 1998 Feb; 172():106-9. PubMed ID: 9519061
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial that pays patients to take antipsychotic drugs comes under attack.
    Eaton L
    BMJ; 2009 Oct; 339():b4202. PubMed ID: 19822620
    [No Abstract]   [Full Text] [Related]  

  • 12. Interpretation of analysis.
    Heller JG
    Can J Clin Pharmacol; 2002; 9(3):129, 153; author reply 153. PubMed ID: 12474874
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine and hospitalization.
    Rosenheck R; Charney D; Cramer J
    Psychiatr Serv; 1999 Jan; 50(1):114-6. PubMed ID: 9890595
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics].
    Gasquet I; Bouhassira M; Launois R
    Encephale; 2005; 31(4 Pt 1):517-8. PubMed ID: 16389719
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical applications of recent antipsychotic effectiveness data.
    J Clin Psychiatry; 2007 Jan; 68(1):151-62. PubMed ID: 17284143
    [No Abstract]   [Full Text] [Related]  

  • 16. Polypharmacy in schizophrenia: a fuzzy concept.
    Freudenreich O; Goff DC
    J Clin Psychiatry; 2003 Sep; 64(9):1132; author reply 1132-3. PubMed ID: 14628993
    [No Abstract]   [Full Text] [Related]  

  • 17. Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication.
    Citrome L
    Int J Clin Pract; 2010 Jan; 64(2):216-39. PubMed ID: 19886879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of long-acting risperidone: what can pharmacoeconomic models teach us?
    Annemans L
    Pharmacoeconomics; 2005; 23 Suppl 1():1-2. PubMed ID: 16416757
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of schizophrenia: let's talk dollars and sense.
    Buckley PF
    Am J Manag Care; 1998 Mar; 4(3):369-83. PubMed ID: 10178499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of capitation on health of the chronically ill. Implications for antipsychotic drug therapy.
    Reed SK; Maharaj K
    Pharmacoeconomics; 1994 Dec; 6(6):506-12. PubMed ID: 10155280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.